Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.
about
Dependence of Golgi apparatus integrity on nitric oxide in vascular cells: implications in pulmonary arterial hypertension.Bone marrow necrosis and fat embolism: an autopsy report of a severe complication of hemoglobin SC diseaseReconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Computed tomography correlates with cardiopulmonary hemodynamics in pulmonary hypertension in adults with sickle cell disease.Numerical simulation of blood flow and pressure drop in the pulmonary arterial and venous circulation.Elevation of plasma cell-free hemoglobin in pulmonary arterial hypertensionMechanistic insights and characterization of sickle cell disease-associated cardiomyopathyThe role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesRisk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network reportA novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease.Peroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell diseaseRelationship between pulmonary and cardiac abnormalities in sickle cell disease: implications for the management of patients.Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionEarly detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward.The role of endothelin-1 in pulmonary arterial hypertension.Mobile Right Atrial Thrombi in a Patient with the Hemoglobin SC Disease.COPD-associated pulmonary hypertension: clinical implications and current methods for treatment.Arginase and arginine dysregulation in asthma.The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom.Severe neonatal congenital erythropoietic porphyria.Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension: A cross-sectional study.Making reasonable decisions: a qualitative study of medical decision making in the care of patients with a clinically significant haemoglobin disorder.Flow cytometric assessment of circulating platelet and erythrocytes microparticles in young thalassemia major patients: relation to pulmonary hypertension and aortic wall stiffness.Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin E/β-thalassemia disease.Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.
P2860
Q30499465-A5F5A3AD-9C43-45FF-9670-5D8C100A3971Q33738014-9844E1B0-C679-4916-B9AE-EE94B0BB6EADQ33803027-5E5CD6D0-7C57-486F-8B07-34DF8F3C9270Q33805998-FA77EFEB-D8BA-4625-BA6A-F05772A3A8ABQ34280409-C39DC989-96D6-484D-9592-0AD46EF7B22BQ34609897-73F79B50-F396-4B0E-A057-E612289F91F5Q35078958-9B0B44D8-D111-48C1-B14D-E4DA6AC9909BQ35156618-635B8D45-A614-4A2C-A7F1-FDD4E2613A61Q35346284-8B2B7A2C-743D-4382-A9D7-BE2756722A33Q36238248-C00E3795-87D5-4CF4-AEE2-E8020C95C321Q36353647-2AFB5D53-73FC-4D1F-B2DB-A4D45A890632Q36674858-8898FDA9-2726-4C2D-B9B4-527324D2275AQ37144856-07F72BD3-CAF3-4F0B-BD98-E298426D2E1BQ37880493-6D9E1AC9-FBD8-4384-A3EB-31F34D6ED40CQ38269052-4CDADBB9-7D97-4CCF-88A8-20675D6B8BEFQ38333866-88B9F741-B19E-4901-B534-C2AA334C9ED2Q38841456-5530B120-BAA3-4377-82BE-AB6EF48DBD32Q41831572-9C79F8CA-5624-458B-AC1A-7AC6484DA496Q44618194-CCDEDECB-6B7C-4B3E-9C13-167B4CA2F00EQ46189082-E923D045-A674-49FF-82F2-7983A18DEC82Q47093315-C26CAF5B-6E4A-4099-8F83-6C84CF93FB7AQ48035208-6694FFF7-1124-4039-B803-87F0FF2648B4Q50493543-58A7C534-BA01-41CB-86BD-1CD6F7763ECCQ53078962-A05D6A35-E2F7-4E61-A726-BDAA2AFD762CQ55427971-E8BF5570-E34C-4B94-91BC-C5534C437113
P2860
Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pulmonary hypertension in hemo ...... sease: the global perspective.
@ast
Pulmonary hypertension in hemo ...... sease: the global perspective.
@en
type
label
Pulmonary hypertension in hemo ...... sease: the global perspective.
@ast
Pulmonary hypertension in hemo ...... sease: the global perspective.
@en
prefLabel
Pulmonary hypertension in hemo ...... sease: the global perspective.
@ast
Pulmonary hypertension in hemo ...... sease: the global perspective.
@en
P2860
P356
P1433
P1476
Pulmonary hypertension in hemo ...... sease: the global perspective.
@en
P2093
Roberto F Machado
P2860
P304
P356
10.1378/CHEST.09-3057
P407
P433
P577
2010-06-01T00:00:00Z